Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

4,700

Employees4,700

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

4,700

Employees4,700

MRNA Key Statistics

Market cap

18.72B

Market cap18.72B

Price-Earnings ratio

-5.79

Price-Earnings ratio-5.79

Dividend yield

—

Dividend yield—

Average volume

5.02M

Average volume5.02M

High today

$49.26

High today$49.26

Low today

$46.82

Low today$46.82

Open price

$47.25

Open price$47.25

Volume

6.32M

Volume6.32M

52 Week high

$59.55

52 Week high$59.55

52 Week low

$22.28

52 Week low$22.28

Stock Snapshot

Moderna(MRNA) stock is priced at $47.28, giving the company a market capitalization of 18.72B. It carries a P/E multiple of -5.79.

On 2026-05-31, Moderna(MRNA) stock moved within a range of $46.82 to $49.26. With shares now at $47.28, the stock is trading +1.0% above its intraday low and -4.0% below the session's peak.

Trading volume for Moderna(MRNA) stock has reached 6.32M, versus its average volume of 5.02M.

Over the past 52 weeks, Moderna(MRNA) stock has traded between a high of $59.55 and a low of $22.28.

MRNA News

Nasdaq 2d

Moderna Now #415 Largest Company, Surpassing Generac Holdings

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Moderna Inc (Symbol: MRNA) has taken over the #415 spot...

TipRanks 3d

Moderna Advances mRNA Lyme Disease Vaccine Into Phase 2: What Investors Should Watch

Moderna (MRNA) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and...

Simply Wall St 5d

Assessing Moderna Valuation After A Strong Yearly Rally And Ongoing Losses

Advertisement Recent performance and context for Moderna (MRNA) Moderna (MRNA) has drawn fresh investor attention after a mixed stretch for the stock, with th...

Analyst ratings

63%

of 27 ratings

Buy

18.5%

Hold

63%

Sell

18.5%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.